arrow_back Back to App

Expanding Access to All FDA-Approved Opioid Overdose Reversal Medications.

This law broadens the definition of life-saving opioid overdose reversal agents eligible for federal grant funding. State and Tribal programs fighting the opioid crisis will no longer be restricted to purchasing only Naloxone, but can use funds for any FDA-approved drug or device designed to reverse an overdose. This change aims to increase the availability and variety of life-saving tools in communities struggling with addiction.
Key points
Federal grants for fighting the opioid crisis (like State Opioid Response Grants) can now fund the purchase of any FDA-approved drug or device for emergency overdose treatment.
The Department of Health and Human Services (HHS) must update existing grant rules by the end of 2023 to remove the limitation to Naloxone.
This provides greater flexibility for states and tribes to choose the most effective and accessible life-saving tools.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_S_2809
Sponsor: Sen. Cornyn, John [R-TX]
Process start date: 2023-09-14
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

HEAL Act of 2023

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_S_2809.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-09-14.

What are the main provisions?

Key points include:

  • Federal grants for fighting the opioid crisis (like State Opioid Response Grants) can now fund the purchase of any FDA-approved drug or device for emergency overdose treatment.
  • The Department of Health and Human Services (HHS) must update existing grant rules by the end of 2023 to remove the limitation to Naloxone.
  • This provides greater flexibility for states and tribes to choose the most effective and accessible life-saving tools.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Cornyn, John [R-TX].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Health